Trending...
- Divorce-Online Marks 25 Years Transforming Family Law Services in the UK
- Sober.Buzz the Sober Token : Ticker $BUZZ
- DuoKey to Unveil Encrypted Financial Intelligence Use Case at GISEC Global 2025
BLOOMFIELD HILLS, Mich. ~ ZIVO Bioscience, Inc. (NASDAQ: ZIVO) has announced an update on the commercialization of its proprietary algal biomass product, Zivolife. Following strong initial sales, ZWorldwide, an independent distributor with exclusive rights to the product in North America, has committed to purchasing at least 24,000 kilograms of product for each of the next five years including the commitment for the initial 18-month period.
The company is collaborating with Alimenta Algae SAC to repurpose their prior microalgae facility into a larger and more efficient cultivation and processing facility that is expected to have the ability to produce up to 100,000 kilograms of dried product per year. The new facility is anticipated to be fully operational in the second or third quarter of 2025. Under the terms of its supply agreement, Alimenta has committed to ZIVO that it will make the necessary investments to the cultivation ponds and to downstream processing.
More on Michimich.com
John Payne, CEO and Chairman of ZIVO Bioscience said "With the successful introduction of Zivolife to the green powder market and sales agreements locked in, we are now actively working with ZWorldwide to drive commercial success and with our contract cultivation partner, Alimenta Algae, to increase production volumes." He added "I am optimistic about the future of ZIVO and the consumer uptake of our algal biomass product. Increasing production volume is a direct path to increasing sales."
Zivolife is natural, non-GMO and a high source of plant-based protein, naturally occurring beta glucan and fiber. It supports digestive and gut health and helps support a healthy immune system. It has a mild taste compared with other microalgae and has been tested as shelf stable for up to two years.
ZIVO Bioscience is a research and development company with an intellectual property portfolio comprised of proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques and patented or patent pending inventions for applications in human and animal health.
Zivolife will initially be available in limited quantities as ZIVO scales up production but with key elements of a commercial strategy in place there is hope that it will become widely available soon.
The company is collaborating with Alimenta Algae SAC to repurpose their prior microalgae facility into a larger and more efficient cultivation and processing facility that is expected to have the ability to produce up to 100,000 kilograms of dried product per year. The new facility is anticipated to be fully operational in the second or third quarter of 2025. Under the terms of its supply agreement, Alimenta has committed to ZIVO that it will make the necessary investments to the cultivation ponds and to downstream processing.
More on Michimich.com
- Robert Fabbio Inducted into the Austin Technology Council Hall of Fame
- Cybersecurity is Protecting Your Personal Information and Your Portfolio
- EY US names Tifiany Walker of Walker Healthforce a finalist for Entrepreneur Of The Year® 2025 Michigan and Northwest Ohio Award
- Michigan Lawn Care Company Begins May Treatment
- Boat Dock Manufacturer Gives Design Tips for Summer!
John Payne, CEO and Chairman of ZIVO Bioscience said "With the successful introduction of Zivolife to the green powder market and sales agreements locked in, we are now actively working with ZWorldwide to drive commercial success and with our contract cultivation partner, Alimenta Algae, to increase production volumes." He added "I am optimistic about the future of ZIVO and the consumer uptake of our algal biomass product. Increasing production volume is a direct path to increasing sales."
Zivolife is natural, non-GMO and a high source of plant-based protein, naturally occurring beta glucan and fiber. It supports digestive and gut health and helps support a healthy immune system. It has a mild taste compared with other microalgae and has been tested as shelf stable for up to two years.
ZIVO Bioscience is a research and development company with an intellectual property portfolio comprised of proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques and patented or patent pending inventions for applications in human and animal health.
Zivolife will initially be available in limited quantities as ZIVO scales up production but with key elements of a commercial strategy in place there is hope that it will become widely available soon.
Filed Under: Business
0 Comments
Latest on Michimich.com
- $56.7 Million Announced in Q1 2025 with Revenue Growth and Progress Toward NASDAQ Uplisting for AI Marketing Company: IQSTEL, Inc. Stock Symbol: IQSTD
- SAVVY MINING raised $500 million and launched BTC.XRP.DOGE cloud mining, increasing investors' returns by 30%
- Centaris Acquires Hi-Tech System Service, Inc. to Expand Regional Footprint and Capabilities
- Celebrate Mother's Day with family dining options from Frankenmuth's Bavarian Inn Restaurants
- New National Nonprofit Launches to Capture Firsthand Accounts of Adoption Stories
- The Tide Project Opens at Biennale Architettura 2025 in Venice Amplifying Youth Voices
- Wall Street analysts say BTC.XRP.DOGE cloud mining company SIX MINING is expected to achieve a 5-fold increase, allowing users to easily mine BTC
- Gen X Takes The Reins: New Book Guides Caregivers Juggling Parents, Kids, And Grandkids With Humor And Heart
- Fray Fitness Launches Memorial Day Sale and Veteran Organization Giveaway
- ABM for Good™ Launches First Project with Build Change
- SLP Couture Presents "Murderous Love"
- ImagineX, in Collaboration with Qualys, Launches New mROC Services to Transform Enterprise Cyber Risk Management
- Ditch Micromanagement: New Leadership Book for Results-Driven, Accountability-Based Teams
- Jay Tapp was named Managing Director in British Columbia
- Hubei Heavy Equipment Makes a Striking Appearance at CIMT and Competes with International Brands
- 20 Patents Issued Worldwide, Cementing Company Leadership. First Ever Cable-Free 12-Lead ECG: HeartBeam, Inc. (Stock Symbol: BEAT)
- NASDAQ Uplisting for Higher Market Exposure and Wide Corporate Benefits to AI Boosted Marketing Company On Track Towards $1 Billion Revenue by 2027
- Frankenmuth Dog Bowl back in action May 24 and 25 with fun at Frankenmuth River Place Shops
- Congressional Men's Health Caucus Shows Bipartisan Consensus and Focus on Prevention, Mental Health, and Closing the Lifespan Gap
- DuoKey, Axiomtek and Blue Edge Network Partner to Enhance Smart Cities with Privacy-Preserving Urban Safeguarding and Fleet Management